Immatics N.V. Files Q2 2024 6-K Report
Ticker: IMTX · Form: 6-K · Filed: Aug 13, 2024 · CIK: 1809196
Sentiment: neutral
Topics: financial-update, collaboration, quarterly-report
Related Tickers: IMTX
TL;DR
Immatics dropped its Q2 6-K, showing R&D and G&A expenses, plus updates on BMS/Moderna deals.
AI Summary
Immatics N.V. filed a 6-K report for the period ending June 30, 2024. The filing includes financial data for the second quarter of 2024, detailing expenses such as Research and Development, and General and Administrative costs. It also references collaborations with companies like BMS and Moderna.
Why It Matters
This filing provides investors with an update on Immatics' financial performance and ongoing collaborations during the second quarter of 2024.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) providing an update on financial data and business activities, not a material event announcement.
Key Players & Entities
- Immatics N.V. (company) — Filer
- BMS (company) — Collaboration Partner
- Moderna (company) — Collaboration Partner
- Genmab (company) — Collaboration Partner
FAQ
What is the reporting period for this 6-K filing?
The Conformed Period of Report is 20240630, indicating the filing covers the period ending June 30, 2024.
What are the main expense categories mentioned in the filing?
The filing mentions ResearchAndDevelopmentExpenseMember and GeneralAndAdministrativeExpenseMember.
Which collaboration agreements are specifically referenced?
The filing references collaborations with BMS (BMSCollaborationAgreementMember), Moderna (ModernaCollaborationAgreementMember), and Genmab (GenmabCollaborationAgreementMember).
What is the company's fiscal year end?
The company's fiscal year end is 1231.
What is the filing's accession number?
The accession number for this filing is 0001193125-24-199384.
Filing Stats: 344 words · 1 min read · ~1 pages · Grade level 9.1 · Accepted 2024-08-13 07:07:01
Filing Documents
- d878211d6k.htm (6-K) — 111KB
- d878211dex991.htm (EX-99.1) — 853KB
- d878211dex992.htm (EX-99.2) — 150KB
- g878211g0809211605330.jpg (GRAPHIC) — 4KB
- 0001193125-24-199384.txt ( ) — 5001KB
- imtx-20240630.xsd (EX-101.SCH) — 60KB
- imtx-20240630_cal.xml (EX-101.CAL) — 47KB
- imtx-20240630_def.xml (EX-101.DEF) — 184KB
- imtx-20240630_lab.xml (EX-101.LAB) — 333KB
- imtx-20240630_pre.xml (EX-101.PRE) — 282KB
- d878211d6k_htm.xml (XML) — 842KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMATICS N.V. Date: August 13, 2024 by: /s/ Harpreet Singh Harpreet Singh Chief Executive Officer 2